Inaktiver Wert

Andere Sprachen Jaguar Health Inc Nasdaq

Aktien

US47010C3007

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Jaguar Health Applies for Investigational New Animal Drug Status for Potential Dog Diarrhea Treatment	06.05.
Jaguar Health, Inc. Establishes New Investigational New Animal Drug File with the Center for Veterinary Medicine of the U.S. Food and Drug Administration	06.05.
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion about Microvillus Inclusion Disease	30.04.
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care	23.04.
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care	19.04.
Venture Life renews revolving credit facility with Santander and HSBC	19.04.
Jaguar Health, Inc. Appoints Catherine Miller Collis to the Role of Senior Vice President of Growth Strategy	18.04.
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders	10.04.
Wall Street Set to Open Sharply Lower Wednesday as Inflation Rises More Than Expected	10.04.
Exchange-Traded Funds Down, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Meeting Minutes	10.04.
Top Premarket Gainers	10.04.
Jaguar Health Granted Extension until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement	09.04.
Jaguar Health : Corporate Presentation – April 1, 2024	05.04.
Jaguar Health, Inc. Appoints Massimo Radaelli, PhD, as President of Jaguar International	04.04.
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International	03.04.
Jaguar Health Reports 2023 Financial Results	02.04.
Jaguar Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials and Corporate Updates	28.03.
Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance	26.02.
Jaguar Health Reaches Agreement With FDA on Design, Conduct of Medicine Study	15.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Jaguar Health Inc Nasdaq

Aktien

US47010C3007

Andere Sprachen

Filter